GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Ludwig Enterprises Inc (OTCPK:LUDG) » Definitions » Debt-to-Equity

Ludwig Enterprises (Ludwig Enterprises) Debt-to-Equity : -0.94 (As of Dec. 2023)


View and export this data going back to 2007. Start your Free Trial

What is Ludwig Enterprises Debt-to-Equity?

Ludwig Enterprises's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $1.37 Mil. Ludwig Enterprises's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was $0.00 Mil. Ludwig Enterprises's Total Stockholders Equity for the quarter that ended in Dec. 2023 was $-1.46 Mil. Ludwig Enterprises's debt to equity for the quarter that ended in Dec. 2023 was -0.94.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Ludwig Enterprises's Debt-to-Equity or its related term are showing as below:

LUDG' s Debt-to-Equity Range Over the Past 10 Years
Min: -1.62   Med: -1.28   Max: -0.94
Current: -0.94

During the past 2 years, the highest Debt-to-Equity Ratio of Ludwig Enterprises was -0.94. The lowest was -1.62. And the median was -1.28.

LUDG's Debt-to-Equity is not ranked
in the Medical Devices & Instruments industry.
Industry Median: 0.21 vs LUDG: -0.94

Ludwig Enterprises Debt-to-Equity Historical Data

The historical data trend for Ludwig Enterprises's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ludwig Enterprises Debt-to-Equity Chart

Ludwig Enterprises Annual Data
Trend Dec22 Dec23
Debt-to-Equity
-1.62 -0.94

Ludwig Enterprises Quarterly Data
Sep22 Dec22 Sep23 Dec23
Debt-to-Equity N/A -1.62 -0.94 -0.94

Competitive Comparison of Ludwig Enterprises's Debt-to-Equity

For the Medical Devices subindustry, Ludwig Enterprises's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Ludwig Enterprises's Debt-to-Equity Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Ludwig Enterprises's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Ludwig Enterprises's Debt-to-Equity falls into.



Ludwig Enterprises Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Ludwig Enterprises's Debt to Equity Ratio for the fiscal year that ended in Dec. 2023 is calculated as

Ludwig Enterprises's Debt to Equity Ratio for the quarter that ended in Dec. 2023 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Ludwig Enterprises  (OTCPK:LUDG) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.


Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.


Ludwig Enterprises Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Ludwig Enterprises's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Ludwig Enterprises (Ludwig Enterprises) Business Description

Traded in Other Exchanges
N/A
Address
1749 VICTORIAN AVENUE, Suite C-350, Sparks, NV, USA, 89431
Ludwig Enterprises Inc is a publicly traded Medical Technology Holding Company with Precision Genomics, Inc. and MyRNA for Life, Inc. as wholly owned subsidiaries. The company's advancements in medical technology and Artificial Intelligence (AI) have awarded it with cutting-edge genomic tools. These genomic tools have the potential to detect diseases early but also to customize treatments that may improve patient outcomes and, in some cases, even extend life. Ludwig is at the forefront of this new era with their proprietary mRNA genetic technology that has the potential to detect genetic biomarkers for inflammatory-driven diseases, including but not limited to heart disease, diabetes, preeclampsia, and cancer. It manages its business on the basis of one operating and reportable segment.